TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Not Specified
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

CG Oncology announced that its Chairman & CEO Arthur Kuan and President & COO Ambaw Bellete will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026. The company is a late-stage clinical biopharmaceutical firm developing bladder-sparing therapeutics for bladder cancer patients, with recent data showing promising efficacy rates for its lead candidate cretostimogene grenadenorepvec in non-muscle invasive bladder cancer.

Insights
AAPL   positive

Thiel significantly increased holdings by purchasing 79,181 shares, showing confidence in the company's future


CGON   positive

The company is presenting at a major healthcare conference and has announced promising clinical data showing high efficacy rates (95.7% at 3-months, 84.6% at 6-months, 80.4% at 9-months) for its lead therapeutic candidate in high-risk bladder cancer patients, indicating progress in late-stage development.